Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
As part of our expanding European organization we seek a visionary and hands‑on Executive Director Commercial Excellence, Analytics & Insights Europe who will play a critical role in architecting the commercial infrastructure for our data‑driven European launch, ensuring operational excellence and strategic execution across the region. This individual will report to the Vice President Commercial and Market Development Europe and will be the bridge between Strategy, Data, Technology and Execution. The role will closely partner with the Global organization and individual country teams, defining forecast and measuring success across all channels (Digital & Field) and driving decision‑making through data.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA; please contact for additional information.
Employment Type: Full Time
Vacancy: 1